These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6524991

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Rénia L, Hannoun L, Eling W, Levy S, Boucheix C, Mazier D.
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [Abstract] [Full Text] [Related]

  • 43. Short report: the activity of pamaquine, an 8-aminoquinoline drug, against sporozoite-induced infections of Plasmodium vivax (New Guinea strains).
    Sweeney AW, Blackburn CR, Rieckmann KH.
    Am J Trop Med Hyg; 2004 Aug; 71(2):187-9. PubMed ID: 15306708
    [Abstract] [Full Text] [Related]

  • 44. [A screening method for tissue schizontocides with Plasmodium yoelii].
    Shao BR, Ye XY, Zheng H.
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):201-6. PubMed ID: 6239514
    [No Abstract] [Full Text] [Related]

  • 45. [A preliminary study on the inhibitory action of target-primaqine on the exoerythrocytic forms of Plasmodium yoelii yoelii].
    Song J, Wang X, Huang F, Feng C, Zhang Z, Huo Y, Pang Q.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995 Sep; 13(2):117-9. PubMed ID: 7554159
    [Abstract] [Full Text] [Related]

  • 46. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection.
    Guha M, Maity P, Choubey V, Mitra K, Reiter RJ, Bandyopadhyay U.
    J Pineal Res; 2007 Nov; 43(4):372-81. PubMed ID: 17910606
    [Abstract] [Full Text] [Related]

  • 47. [Synthesis of primaquine analogues and their antimalarial activity in mice].
    Jiang Q, Zhong J, Shi Y, Li G.
    Yao Xue Xue Bao; 1998 Nov; 33(3):194-200. PubMed ID: 11938965
    [Abstract] [Full Text] [Related]

  • 48. Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
    Agrawal A, Tripathi LM, Pandey VC.
    Indian J Exp Biol; 1997 Nov; 35(11):1194-7. PubMed ID: 9567749
    [Abstract] [Full Text] [Related]

  • 49. [Morphological characteristics of Plasmodium yoelii schizonts in ghost erythrocytes].
    Mao YH, Xu B, Liu BF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):263-7. PubMed ID: 15266827
    [Abstract] [Full Text] [Related]

  • 50. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A, Dutta GP, Bhakuni V, Tripathi R.
    Exp Parasitol; 2004 Jun; 107(3-4):115-9. PubMed ID: 15363936
    [Abstract] [Full Text] [Related]

  • 51. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ, Alhomida AS, Dutta GP, Pandey VC.
    In Vivo; 2002 Jun; 16(1):67-70. PubMed ID: 11980364
    [Abstract] [Full Text] [Related]

  • 52. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.
    Silvie O, Greco C, Franetich JF, Dubart-Kupperschmitt A, Hannoun L, van Gemert GJ, Sauerwein RW, Levy S, Boucheix C, Rubinstein E, Mazier D.
    Cell Microbiol; 2006 Jul; 8(7):1134-46. PubMed ID: 16819966
    [Abstract] [Full Text] [Related]

  • 53. Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice.
    Srivastava P, Pandey VC.
    Ecotoxicol Environ Saf; 2000 May; 46(1):19-22. PubMed ID: 10805988
    [Abstract] [Full Text] [Related]

  • 54. Tafenoquine: First Global Approval.
    Frampton JE.
    Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
    [Abstract] [Full Text] [Related]

  • 55. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
    Vanderberg JP, Khan ZM, Stewart MJ.
    J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
    [Abstract] [Full Text] [Related]

  • 56. The chemotherapy of rodent malaira. XV. Fine-structural studies on the sporogonic stages of Plasmodium berghei following exposure to primaquine.
    Davies EE, Howells RE, Peters W.
    Ann Trop Med Parasitol; 1971 Dec; 65(4):461-4. PubMed ID: 5145110
    [No Abstract] [Full Text] [Related]

  • 57. Primaquine revisited six decades after its discovery.
    Vale N, Moreira R, Gomes P.
    Eur J Med Chem; 2009 Mar; 44(3):937-53. PubMed ID: 18930565
    [Abstract] [Full Text] [Related]

  • 58. [Epidemiology and prophylaxis of malaria in France (author's transl)].
    Bastin R, Charmot G.
    Nouv Presse Med; 1980 Mar 22; 9(14):1003-6. PubMed ID: 6988801
    [Abstract] [Full Text] [Related]

  • 59. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
    Brueckner RP, Coster T, Wesche DL, Shmuklarsky M, Schuster BG.
    Antimicrob Agents Chemother; 1998 May 22; 42(5):1293-4. PubMed ID: 9593172
    [Abstract] [Full Text] [Related]

  • 60. Radical curative activity of a new 8-aminoquinoline derivative (CDRI 80/53) against Plasmodium cynomolgi B in monkeys.
    Dutta GP, Puri SK, Bhaduri AP, Seth M.
    Am J Trop Med Hyg; 1989 Dec 22; 41(6):635-7. PubMed ID: 2641640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.